by Acellular dermal matrices or ADMs are human tissue allografts harvested from donated human skin and processed to remove the epidermis, cells and cellular components while preserving the dermal protein matrix. They are used in a wide range of surgical procedures such as breast reconstruction, abdominal wall reconstruction, orbital floor reconstruction, etc. for replacement or regeneration of soft tissue. The allograft is highly biocompatible, provides strength, induces host cell repopulation, promotes revascularization and wound healing.
The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Key Trends:
One of the key trends in the U.S. Acellular Dermal Matrices Market is the growing preference for ADM meshes derived from donated human skin. These ready-to-use allografts offer several advantages over synthetic meshes like lower infection risk, better biocompatibility, minimal rejection and ability to reconstruct complex anatomical areas with precision. They also eliminate the need for autologous tissue harvest from patients, thereby avoiding donor site morbidity. Moreover, researchers are working on further optimizing processing techniques to enhance properties like strength, biostability and promote host tissue integration of ADM meshes. This is expected to widen their applications and drive higher demand over the forecast period.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the U.S. acellular dermal matrices market is low due to high R&D and manufacturing costs.
Bargaining power of buyers: The bargaining power of buyers in the U.S. acellular dermal matrices market is moderate due to the presence of substitutes.
Bargaining power of suppliers: The bargaining power of suppliers in the U.S. acellular dermal matrices market is low due to the dominance of established players.
Threat of new substitutes: The threat of new substitutes in the U.S. acellular dermal matrices market is moderate due to the availability of alternative wound care products.
Competitive rivalry: The competitive rivalry in the U.S. acellular dermal matrices market is high due to the presence of numerous established players.
Key Takeaways
The Global U.S. Acellular Dermal Matrices Market Size is expected to witness high growth. The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030.
Regional analysis: The South region dominated the U.S. acellular dermal matrices market in 2023, accounting for nearly 30% of global market share. Growing geriatric population and increasing number of wound care centers are key factors driving market growth in the South.
Key players: Key players operating in the U.S. Acellular Dermal Matrices market are Biomet, Inc., Wright Medical Technology, Inc., Smith & Nephew Plc, and Stryker. Biomet, Inc. held the leading market share of around 25% in 2023 owing to its wide product portfolio.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
